| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | 0.009 | 0.8 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | -0.0084 | 0.8 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | 0.0078 | 0.8 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | -0.0084 | 0.8 |
| mRNA | spautin-1 | CTRPv2 | pan-cancer | AAC | 0.0079 | 0.8 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | 0.0079 | 0.8 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | 0.0078 | 0.8 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0075 | 0.8 |
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | 0.0076 | 0.8 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.011 | 0.8 |